About Us

DRI Faculty

Scientific Advisory Board

Scientific Advisory Board (SAB)

The Scientific Advisory Board (SAB) at the Diabetes Research Institute (DRI), as part of the University of Miami, serves as an external consultant to the Diabetes Research Institute. Composed of several distinguished scientists who have earned international recognition for their contributions to diabetes research, the SAB is tasked with guiding, evaluating, and advancing the DRI’s research programs. Members meet on a regular basis and collaborate to review ongoing projects, provide strategic advice, recommend key experiments, and help shape the scientific direction to ensure impactful outcomes. This rigorous evaluation process is designed to foster innovation and ensure that the research conducted has a significant impact on the field of diabetes research. The SAB’s expertise and strategic guidance are integral to the DRI’s commitment to pioneering research that aims to understand, treat, and ultimately cure diabetes.

Andrew Stewart, M.D. (Chair)

Director, Diabetes, Obesity and Metabolism Institute
Irene and Dr. Arthur M Fishberg Professor
Icahn School of Medicine at Mount Sinai
New York, NY

Christopher B. Newgard, Ph.D.

Director, Sarah W. Stedman Nutrition and Metabolism Center
Director, Duke Molecular Physiology Institute
W. David and Sarah W. Stedman Distinguished Professor
Duke Medical Alumni Association Distinguished Professor
Duke University Medical Center
Durham, NC

Todd Brusko, M.D.

Professor, Department of Pathology, Immunology and Laboratory Medicine,
University of Florida
Gainesville, Florida

Carmella Evans-Molina, Ph.D.,M.S., M.D.

Director, Indiana Diabetes Research Center
School of Medicine, Indiana University
Indianapolis, IN

Alessandro Grattoni, Ph.D., M.S., M.D.

Professor of Nanomedicine, Academic Institute
Full Member, Research Institute
Chair, Department of Nanomedicine
Frank J. and Jean Raymond Centennial Chair, Houston Methodist
Houston, Texas